Literature DB >> 25268803

Heparan sulfate saccharides modify focal adhesions: implication in mucopolysaccharidosis neuropathophysiology.

Julie Bruyère1, Elise Roy1, Jérôme Ausseil2, Thomas Lemonnier1, Guillaume Teyre1, Delphine Bohl1, Sandrine Etienne-Manneville3, Hugues Lortat-Jacob4, Jean Michel Heard5, Sandrine Vitry1.   

Abstract

Mucopolysaccharidoses type III (MPSIII, Sanfilippo syndrome) are genetic diseases due to deficient heparan sulfate (HS) saccharide digestion by lysosomal exoglycanases. Progressive accumulation of undigested saccharides causes early-onset behavioural and cognitive symptoms. The precise role of these saccharides in the pathophysiological cascade is still unclear. We showed that exposure of wild-type neural cells to exogenous soluble HS fragments of at least eight saccharides activated integrin-based focal adhesions (FAs), which attach cells to the extracellular matrix. FAs were constitutively activated in MPSIII type B astrocytes or neural stem cells unless undigested saccharides were cleared by exogenous supply of the missing exoglycanase. Defective cell polarisation and oriented migration in response to focal extracellular stimuli in affected cells suggest improper sensing of the environment. We consistently observed abnormal organisation of the rostral migratory stream in the brain of adult mice with MPSIII type B. These results suggest that cell polarisation and oriented migration defects participate to the neurological disorders associated with Sanfilippo syndrome.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cell polarisation; focal adhesion; glycosaminoglycans; mucopolysaccharidosis; neural cell migration

Mesh:

Substances:

Year:  2014        PMID: 25268803     DOI: 10.1016/j.jmb.2014.09.012

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

1.  Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model.

Authors:  Carla Martins; Helena Hůlková; Larbi Dridi; Virginie Dormoy-Raclet; Lubov Grigoryeva; Yoo Choi; Alexander Langford-Smith; Fiona L Wilkinson; Kazuhiro Ohmi; Graziella DiCristo; Edith Hamel; Jerôme Ausseil; David Cheillan; Alain Moreau; Eva Svobodová; Zuzana Hájková; Markéta Tesařová; Hana Hansíková; Brian W Bigger; Martin Hrebícek; Alexey V Pshezhetsky
Journal:  Brain       Date:  2015-01-06       Impact factor: 13.501

2.  The efficacy of intracerebroventricular idursulfase-beta enzyme replacement therapy in mucopolysaccharidosis II murine model: heparan sulfate in cerebrospinal fluid as a clinical biomarker of neuropathology.

Authors:  Young Bae Sohn; Ah-Ra Ko; Mi-Ran Seong; Soyeon Lee; Mi Ra Kim; Sung Yoon Cho; Jung-Sun Kim; Makoto Sakaguchi; Takahiro Nakazawa; Motomichi Kosuga; Joo Hyun Seo; Torayuki Okuyama; Dong-Kyu Jin
Journal:  J Inherit Metab Dis       Date:  2018-07-05       Impact factor: 4.982

3.  Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine.

Authors:  G V Coppa; O Gabrielli; L Zampini; F Maccari; V Mantovani; T Galeazzi; L Santoro; L Padella; R L Marchesiello; F Galeotti; N Volpi
Journal:  Metab Brain Dis       Date:  2015-05-29       Impact factor: 3.584

4.  Myotonic dystrophy RNA toxicity alters morphology, adhesion and migration of mouse and human astrocytes.

Authors:  Diana M Dincã; Louison Lallemant; Anchel González-Barriga; Noémie Cresto; Sandra O Braz; Géraldine Sicot; Laure-Elise Pillet; Hélène Polvèche; Paul Magneron; Aline Huguet-Lachon; Hélène Benyamine; Cuauhtli N Azotla-Vilchis; Luis E Agonizantes-Juárez; Julie Tahraoui-Bories; Cécile Martinat; Oscar Hernández-Hernández; Didier Auboeuf; Nathalie Rouach; Cyril F Bourgeois; Geneviève Gourdon; Mário Gomes-Pereira
Journal:  Nat Commun       Date:  2022-07-04       Impact factor: 17.694

5.  Convergent molecular mechanisms underlying cognitive impairment in mucopolysaccharidosis type II.

Authors:  Thiago Corrêa; Fabiano Poswar; Cíntia B Santos-Rebouças
Journal:  Metab Brain Dis       Date:  2021-11-19       Impact factor: 3.655

6.  Immune-Mediated Inflammation May Contribute to the Pathogenesis of Cardiovascular Disease in Mucopolysaccharidosis Type I.

Authors:  Omar Khalid; Moin U Vera; Philip L Gordts; N Matthew Ellinwood; Philip H Schwartz; Patricia I Dickson; Jeffrey D Esko; Raymond Y Wang
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

7.  Neurodevelopmental Changes in Excitatory Synaptic Structure and Function in the Cerebral Cortex of Sanfilippo Syndrome IIIA Mice.

Authors:  Chrissa A Dwyer; Samantha L Scudder; Ying Lin; Lara E Dozier; Dustin Phan; Nicola J Allen; Gentry N Patrick; Jeffrey D Esko
Journal:  Sci Rep       Date:  2017-04-18       Impact factor: 4.379

8.  Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of huntingtin.

Authors:  Julie Bruyère; Yah-Se Abada; Hélène Vitet; Gaëlle Fontaine; Jean-Christophe Deloulme; Aurélia Cès; Eric Denarier; Karin Pernet-Gallay; Annie Andrieux; Sandrine Humbert; Marie-Claude Potier; Benoît Delatour; Frédéric Saudou
Journal:  Elife       Date:  2020-05-26       Impact factor: 8.140

9.  Bi-allelic Pathogenic Variants in HS2ST1 Cause a Syndrome Characterized by Developmental Delay and Corpus Callosum, Skeletal, and Renal Abnormalities.

Authors:  Pauline E Schneeberger; Leonie von Elsner; Emma L Barker; Peter Meinecke; Iris Marquardt; Malik Alawi; Katharina Steindl; Pascal Joset; Anita Rauch; Petra J G Zwijnenburg; Marjan M Weiss; Catherine L R Merry; Kerstin Kutsche
Journal:  Am J Hum Genet       Date:  2020-11-06       Impact factor: 11.025

Review 10.  Molecular Bases of Neurodegeneration and Cognitive Decline, the Major Burden of Sanfilippo Disease.

Authors:  Rachel Heon-Roberts; Annie L A Nguyen; Alexey V Pshezhetsky
Journal:  J Clin Med       Date:  2020-01-27       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.